IVL and neoplasm: In contrast, despite BRAFV600E-driven activation of MAPK signalling reaching similar levels in the progenitor population (IVL+) (Supplementary Fig. 2e), tumours exhibited a longer onset latency (125 days to tumour onset) and grew slowly (Fig. 2c, e).